Using Acute Optic Neuritis Trials to Assess Neuroprotective and Remyelinating Therapies in Multiple Sclerosis

IMPORTANCE: Neuroprotective and remyelinating therapies are required for multiple sclerosis (MS), and acute optic neuritis (AON) is a potential condition to evaluate such treatments. OBJECTIVE: To comprehensively assess key biological and methodological aspects of AON trials for testing neuroprotect...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:JAMA Neurol
Glavni autori: Andorrà, Magí, Alba-Arbalat, Salut, Camos-Carreras, Anna, Gabilondo, Iñigo, Fraga-Pumar, Elena, Torres-Torres, Ruben, Pulido-Valdeolivas, Irene, Tercero-Uribe, Ana I., Guerrero-Zamora, Ana M., Ortiz-Perez, Santiago, Zubizarreta, Irati, Sola-Valls, Nuria, Llufriu, Sara, Sepulveda, Maria, Martinez-Hernandez, Eugenia, Armangue, Thais, Blanco, Yolanda, Villoslada, Pablo, Sanchez-Dalmau, Bernardo, Saiz, Albert, Martinez-Lapiscina, Elena H.
Format: Artigo
Jezik:Inglês
Izdano: American Medical Association 2019
Teme:
Original Investigation
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6777247/
https://ncbi.nlm.nih.gov/pubmed/31566686
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamaneurol.2019.3283
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items